Skip to main content

Loading market data...

MOH

Molina Healthcare, Inc.

NYSE • United states

$214.90

-$4.82

(-2.19%)

Source: Yahoo Finance · Quote time Oct 21, 2026 20:04 GMT+0000

Catalyst Evidence

No verified catalyst stored yet

Click “View” to see the stored chain of evidence (if available).

Management
Credibility
Score

Molina Healthcare, Inc. (MOH)

Unavailable

Quotes may be delayed

$11.22B

Market Cap

1,173,413

Volume

Unavailable

P/E Ratio

Unavailable

Div Yield

Molina Healthcare, Inc. Price Chart

Loading price history…

Management Credibility Analysis

Unavailable

Verified Management Score Unavailable

Management credibility requires sourced guidance and earnings history.

Upcoming Catalysts

Verified event feed

Verified Catalysts Unavailable

No sourced upcoming event feed is configured for this stock yet.

Company profile

No description available

Chief executive: Not disclosed
Headquarters: 200 OCEANGATE, SUITE 100, LONG BEACH, CA
Founded: Not disclosed

📈 Company Timeline

Major business events

Positive

Negative

Neutral

21 Oct 2026

Molina Healthcare, Inc. reported Operating or financial results

Molina Healthcare, Inc. filed an 8-K covering operating or financial results, supporting financial statements or exhibits.

3 Sep 2026

Large-holder ownership filing

A holder reported or amended a beneficial ownership position of more than 5% in Molina Healthcare, Inc..

13 Aug 2026

Large-holder ownership filing

A holder reported or amended a beneficial ownership position of more than 5% in Molina Healthcare, Inc..

12 Aug 2026

Large-holder ownership filing

A holder reported or amended a beneficial ownership position of more than 5% in Molina Healthcare, Inc..

6 Aug 2026

Large-holder ownership filing

A holder reported or amended a beneficial ownership position of more than 5% in Molina Healthcare, Inc..

Capital Structure & Financial Position

Financial strength and liquidity analysis

Cash and equivalents (USD)$4.99B

Total assets (USD)$16.00B

Total liabilities (USD)$11.83B

Shareholders' equity (USD)$4.17B

Long-term debt (USD)$3.77B

Debt due within a year (USD)$0

Source: SEC EDGAR company facts (opens in a new tab) Balance sheet dated 30 Jun 2026

Peer Comparison - Health Care

Company	Price	Market Cap
LLY - Eli Lilly and Company	$1,276.13 Yahoo Finance	$1.20T
JNJ - Johnson & Johnson	$256.74 Yahoo Finance	$618.71B
ABBV - AbbVie Inc.	$284.80 Yahoo Finance	$503.28B
UNH - UnitedHealth Group Incorporated	$418.43 Yahoo Finance	$375.58B
MRK - Merck & Co., Inc.	$148.55 Yahoo Finance	$366.50B

📋 Corporate Actions

Recent and upcoming corporate events

Verified Corporate Actions Unavailable

Dividend, buyback, split, and spin-off feeds are not ingested for this stock yet.

Financials

Financial statements and key metrics analysis

Quarter	Revenue (USD)	Operating income	Net income	Diluted EPS (USD)	Filed
Q2 2026	$10.87B	$145.00M	$60.00M	$1.19	10-Q · 23 Jul 2026
Q1 2026	$10.80B	$83.00M	$14.00M	$0.27	10-Q · 23 Apr 2026
Q4 2025	$11.38B	−$162.00M	−$160.00M	Unavailable	10-K · 10 Feb 2026
Q3 2025	$11.48B	$137.00M	$79.00M	$1.51	10-Q · 23 Oct 2025
Q2 2025	$11.43B	$373.00M	$255.00M	$4.75	10-Q · 24 Jul 2025
Q1 2025	$11.15B	$433.00M	$298.00M	$5.45	10-Q · 24 Apr 2025

Source: SEC EDGAR company facts (opens in a new tab)

Analyst Consensus

Neutral

Target: $210.25

-2.2% upside potential

📈

Strong Buy

Unavailable

👍

Buy

2

⏸️

Hold

11

📉

Sell

1

14 analysts covering this stock

Source: Nasdaq analyst research (opens in a new tab) Retrieved 21 Oct 2026, 22:47 UTC Targets range 156.00–266.00 Ratings are third-party opinions, not advice.

💰 Upcoming Dividends

Next dividend payments

Verified Dividend Data Unavailable

Dividend calendar data is not ingested for this stock yet.

Guidance Evolution

Verified Guidance History Unavailable

Verified company guidance history is not ingested for this stock yet.

💼 Director Transactions

Recent insider activity

1

Oct 2026

ZORETIC RICHARD C

Director

Grant or award

$180.85 per share

304 shares

1

Oct 2026

WOLF DALE B

Director

Grant or award

$180.85 per share

304 shares

1

Oct 2026

Schapiro Richard M

Director

Grant or award

$180.85 per share

304 shares

1

Oct 2026

ROMNEY RONNA

Director

Grant or award

$180.85 per share

304 shares

1

Oct 2026

ORLANDO STEVEN J

Director

Grant or award

$180.85 per share

304 shares

1

Oct 2026

Lockhart Stephen H

Director

Grant or award

$180.85 per share

304 shares

1

Oct 2026

GROHOWSKI LEO P

Director

Grant or award

$180.85 per share

304 shares

1

Oct 2026

SOISTMAN FRANCIS S JR

Director

Grant or award

$180.85 per share

304 shares

Top Shareholders

Blackrock, Inc.

6,572,156 shares

3.189% change

6/30/2026

Vanguard Group Inc

6,083,536 shares

-5.487% change

12/31/2025

Aqr Capital Management Llc

3,560,601 shares

24.349% change

6/30/2026

Vanguard Portfolio Management Llc

2,790,243 shares

-0.026% change

6/30/2026

Capital World Investors

2,562,913 shares

-19.893% change

6/30/2026

Lingotto Investment Management Llp

2,511,490 shares

New% change

6/30/2026

Vanguard Capital Management Llc

2,355,261 shares

1.949% change

6/30/2026

Victory Capital Management Inc

1,980,615 shares

-4.35% change

6/30/2026

Fmr Llc

1,871,290 shares

-41.612% change

6/30/2026

State Street Corp

1,755,467 shares

1.446% change

6/30/2026

Source: Nasdaq institutional holdings (opens in a new tab) Observed 21 Oct 2026, 22:47 UTC· 9 hours ago

Research coverage and investment tools

Molina Healthcare, Inc. (MOH) is a stock listed on the New York Stock Exchange in the United States, in the Health Care sector (Medical Specialities). Its last price was US$214.90 on 21 Oct 2026. That is 76% of the way from its 52-week low of US$121.06 to its 52-week high of US$244.89. Its market capitalisation was US$11.22 billion at that price.

Watch Add to portfolio Set an alert Compare Position size

How position sizing works Dividend yield and total return

Quarter	Revenue	Operating income	Net income	Diluted EPS	Gross margin	Operating margin	Free cash flow	Filed
Q2 2026	$10.87B	$145.00M	$60.00M	$1.19	—	1.3%	−$324.00M	10-Q · 23 Jul 2026 (opens in a new tab)
Q1 2026	$10.80B	$83.00M	$14.00M	$0.27	—	0.8%	$1.06B	10-Q · 23 Apr 2026 (opens in a new tab)
Q4 2025	$11.38B	−$162.00M	−$160.00M	Unavailable	—	-1.4%	−$297.00M	10-K · 10 Feb 2026 (opens in a new tab)
Q3 2025	$11.48B	$137.00M	$79.00M	$1.51	—	1.2%	−$163.00M	10-Q · 23 Oct 2025 (opens in a new tab)
Q2 2025	$11.43B	$373.00M	$255.00M	$4.75	—	3.3%	−$344.00M	10-Q · 24 Jul 2025 (opens in a new tab)
Q1 2025	$11.15B	$433.00M	$298.00M	$5.45	—	3.9%	$168.00M	10-Q · 24 Apr 2025 (opens in a new tab)

Quarter ended	Reported	EPS	Consensus	Surprise
Jun 2026	7/22/2026	$1.51	$1.37	+10.2%
Mar 2026	4/22/2026	$2.35	$1.57	+49.7%
Dec 2025	2/5/2026	−$2.75	$0.43	-739.5%
Sep 2025	10/22/2025	$1.84	$3.97	-53.7%

Cash and equivalents: $4.99B
Total assets: $16.00B
Total liabilities: $11.83B
Shareholders' equity: $4.17B
Long-term debt: $3.77B
Debt due within a year: $0

8-K · 21 Oct 2026

Molina Healthcare, Inc. reported Operating or financial results (opens in a new tab)

Molina Healthcare, Inc. filed an 8-K covering operating or financial results, supporting financial statements or exhibits.
SCHEDULE 13G · 3 Sep 2026

Large-holder ownership filing (opens in a new tab)

A holder reported or amended a beneficial ownership position of more than 5% in Molina Healthcare, Inc..
SCHEDULE 13G/A · 13 Aug 2026

Large-holder ownership filing (opens in a new tab)

A holder reported or amended a beneficial ownership position of more than 5% in Molina Healthcare, Inc..
SCHEDULE 13G/A · 12 Aug 2026

Large-holder ownership filing (opens in a new tab)

A holder reported or amended a beneficial ownership position of more than 5% in Molina Healthcare, Inc..
SCHEDULE 13G/A · 6 Aug 2026

Large-holder ownership filing (opens in a new tab)

A holder reported or amended a beneficial ownership position of more than 5% in Molina Healthcare, Inc..

Insider	Date	Transaction	Shares	Average price	Filing
ZORETIC RICHARD C Director	1 Oct 2026	Grant or award (A)	+304	$180.85	Form 4 (opens in a new tab)
WOLF DALE B Director	1 Oct 2026	Grant or award (A)	+304	$180.85	Form 4 (opens in a new tab)
Schapiro Richard M Director	1 Oct 2026	Grant or award (A)	+304	$180.85	Form 4 (opens in a new tab)
ROMNEY RONNA Director	1 Oct 2026	Grant or award (A)	+304	$180.85	Form 4 (opens in a new tab)
ORLANDO STEVEN J Director	1 Oct 2026	Grant or award (A)	+304	$180.85	Form 4 (opens in a new tab)
Lockhart Stephen H Director	1 Oct 2026	Grant or award (A)	+304	$180.85	Form 4 (opens in a new tab)
GROHOWSKI LEO P Director	1 Oct 2026	Grant or award (A)	+304	$180.85	Form 4 (opens in a new tab)
SOISTMAN FRANCIS S JR Director	1 Oct 2026	Grant or award (A)	+304	$180.85	Form 4 (opens in a new tab)

Institution	Report date	Shares	Change
Blackrock, Inc.	6/30/2026	6,572,156	3.189%
Vanguard Group Inc	12/31/2025	6,083,536	-5.487%
Aqr Capital Management Llc	6/30/2026	3,560,601	24.349%
Vanguard Portfolio Management Llc	6/30/2026	2,790,243	-0.026%
Capital World Investors	6/30/2026	2,562,913	-19.893%
Lingotto Investment Management Llp	6/30/2026	2,511,490	New
Vanguard Capital Management Llc	6/30/2026	2,355,261	1.949%
Victory Capital Management Inc	6/30/2026	1,980,615	-4.35%
Fmr Llc	6/30/2026	1,871,290	-41.612%
State Street Corp	6/30/2026	1,755,467	1.446%

Previous close: 219.72 USD
Day range: 211.66 – 221.68 USD
52-week range: 121.06 – 244.89 USD
Volume: 1,173,413
Market cap: $11.22B
Average volume: 449,689
EPS (FY 2025, diluted): 8.92 USD
Shares outstanding: 52.20M
Beta (5Y monthly): 0.76

Price, ranges and volume: Yahoo Finance (opens in a new tab) Observed 21 Oct 2026, 20:04 UTC· 11 hours ago

Average volume, P/E and shares: Nasdaq (opens in a new tab) Observed 22 Oct 2026, 06:33 UTC· 1 hour ago

EPS: SEC EDGAR company facts (opens in a new tab)

Beta: 5 years of monthly returns against the S&P 500, calculated from Yahoo Finance prices. Market cap is the price × shares outstanding.

This research is not available for MOH yet

Guidance history

IMPORTANT FINANCIAL DISCLAIMER: The information provided on this platform is for educational and informational purposes only and should not be construed as investment advice. All investments involve risk, including potential loss of principal. Past performance does not guarantee future results. Take Profits is not a registered investment advisor and does not provide personalized investment advice. Users should conduct their own research and consult with qualified financial professionals before making investment decisions. Market data may be delayed and is provided by third-party sources.